Search research articles
Contact Us
Filters
Showing results (11-20 of 69) with videos related to
Page
of 7
Sort By:
Hepatology (Baltimore, Md.)
|
April 12, 2024
Non-invasive tests for alcohol-associated liver disease
Mads Israelsen, Wiramon Rungratanawanich, Maja Thiele, et al.
Journal of Hepatology
|
January 19, 2026
Is liver steatosis a disease or the emperor's new clothes?
Aleksander Krag, Frank Tacke, Mads Israelsen, et al.
The Lancet. Gastroenterology & Hepatology
|
January 24, 2025
Reporting discrepancy of alcohol intake affecting estimated prevalence of MetALD and ALD
Aleksander Krag, Nikolaj Torp, Zobair M Younossi, et al.
Lancet (London, England)
|
November 2, 2024
Steatotic liver disease
Mads Israelsen, Sven Francque, Emmanuel A Tsochatzis, et al.
Ugeskrift for Laeger
|
July 9, 2019
[Statins are safe in patients with liver diseases and may have a beneficial effect]
Mie Balle Hugger, Mads Israelsen, Camilla Dalby Hansen, et al.
The Lancet. Gastroenterology & Hepatology
|
August 11, 2023
MetALD: new opportunities to understand the role of alcohol in steatotic liver disease
Mads Israelsen, Nikolaj Torp, Stine Johansen, et al.
The Lancet. Gastroenterology & Hepatology
|
June 10, 2023
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease - Authors' reply
Mads Israelsen, Nikolaj Torp, Stine Johansen, et al.
Annals of Hepatology
|
October 11, 2025
Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trial
Nikolaj Torp, Nick Freemantle, Mads Israelsen, et al.
Journal of Hepatology
|
November 7, 2025
Limited clinical utility of serum-based ELISA PEth compared with whole-blood LC-MS/MS PEth to quantify alcohol consumption
Nikolaj Torp, Mads Israelsen, Michael Estep, et al.
Journal of Hepatology
|
August 4, 2025
Phosphatidylethanol in steatotic liver disease
Nikolaj Torp, Mads Israelsen, Maja Thiele, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 69) with videos related to
Sort By:
Page
of 7
Hepatology (Baltimore, Md.)
|
April 12, 2024
Non-invasive tests for alcohol-associated liver disease
Mads Israelsen, Wiramon Rungratanawanich, Maja Thiele, et al.
Journal of Hepatology
|
January 19, 2026
Is liver steatosis a disease or the emperor's new clothes?
Aleksander Krag, Frank Tacke, Mads Israelsen, et al.
The Lancet. Gastroenterology & Hepatology
|
January 24, 2025
Reporting discrepancy of alcohol intake affecting estimated prevalence of MetALD and ALD
Aleksander Krag, Nikolaj Torp, Zobair M Younossi, et al.
Lancet (London, England)
|
November 2, 2024
Steatotic liver disease
Mads Israelsen, Sven Francque, Emmanuel A Tsochatzis, et al.
Ugeskrift for Laeger
|
July 9, 2019
[Statins are safe in patients with liver diseases and may have a beneficial effect]
Mie Balle Hugger, Mads Israelsen, Camilla Dalby Hansen, et al.
The Lancet. Gastroenterology & Hepatology
|
August 11, 2023
MetALD: new opportunities to understand the role of alcohol in steatotic liver disease
Mads Israelsen, Nikolaj Torp, Stine Johansen, et al.
The Lancet. Gastroenterology & Hepatology
|
June 10, 2023
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease - Authors' reply
Mads Israelsen, Nikolaj Torp, Stine Johansen, et al.
Annals of Hepatology
|
October 11, 2025
Limitations of MELD and MELD 3.0 for prognostication in patients with cirrhosis hospitalized with acute decompensation: an analysis of the ATTIRE trial
Nikolaj Torp, Nick Freemantle, Mads Israelsen, et al.
Journal of Hepatology
|
November 7, 2025
Limited clinical utility of serum-based ELISA PEth compared with whole-blood LC-MS/MS PEth to quantify alcohol consumption
Nikolaj Torp, Mads Israelsen, Michael Estep, et al.
Journal of Hepatology
|
August 4, 2025
Phosphatidylethanol in steatotic liver disease
Nikolaj Torp, Mads Israelsen, Maja Thiele, et al.
Page
of 7